These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 1662289)
21. Topoisomerase II-mediated DNA cleavage activity induced by ellipticines on the human tumor cell line N417. Multon E; Riou JF; LeFevre D; Ahomadegbe JC; Riou G Biochem Pharmacol; 1989 Jul; 38(13):2077-86. PubMed ID: 2544183 [TBL] [Abstract][Full Text] [Related]
22. An antitumor drug-induced topoisomerase cleavage complex blocks a bacteriophage T4 replication fork in vivo. Hong G; Kreuzer KN Mol Cell Biol; 2000 Jan; 20(2):594-603. PubMed ID: 10611238 [TBL] [Abstract][Full Text] [Related]
23. Decreased nuclear matrix DNA topoisomerase II in human leukemia cells resistant to VM-26 and m-AMSA. Fernandes DJ; Danks MK; Beck WT Biochemistry; 1990 May; 29(17):4235-41. PubMed ID: 2163274 [TBL] [Abstract][Full Text] [Related]
24. DNA topoisomerases I & II cleavage sites in the type 1 human immunodeficiency virus (HIV-1) DNA promoter region. Pommier Y; Poddevin B; Gupta M; Jenkins J Biochem Biophys Res Commun; 1994 Dec; 205(3):1601-9. PubMed ID: 7811242 [TBL] [Abstract][Full Text] [Related]
25. Identification within the simian virus 40 genome of a chromosomal loop attachment site that contains topoisomerase II cleavage sites. Pommier Y; Cockerill PN; Kohn KW; Garrard WT J Virol; 1990 Jan; 64(1):419-23. PubMed ID: 2152827 [TBL] [Abstract][Full Text] [Related]
26. Nuclear matrix attachment regions and topoisomerase II binding and reaction sites in the vicinity of a chicken DNA replication origin. Razin SV; Vassetzky YS; Hancock R Biochem Biophys Res Commun; 1991 May; 177(1):265-70. PubMed ID: 1645958 [TBL] [Abstract][Full Text] [Related]
27. Analysis of the DNA topoisomerase-II-mediated cleavage of the long terminal repeat of Drosophila 1731 retrotransposon. Nahon E; Best-Belpomme M; Saucier JM Eur J Biochem; 1993 Nov; 218(1):95-102. PubMed ID: 8243480 [TBL] [Abstract][Full Text] [Related]
28. Effects of DNA intercalating agents on topoisomerase II induced DNA strand cleavage in isolated mammalian cell nuclei. Pommier Y; Schwartz RE; Zwelling LA; Kohn KW Biochemistry; 1985 Nov; 24(23):6406-10. PubMed ID: 3002439 [TBL] [Abstract][Full Text] [Related]
30. DNA minor groove binding agents interfere with topoisomerase II mediated lesions induced by epipodophyllotoxin derivative VM-26 and acridine derivative m-AMSA in nuclei from L1210 cells. Woynarowski JM; Sigmund RD; Beerman TA Biochemistry; 1989 May; 28(9):3850-5. PubMed ID: 2473776 [TBL] [Abstract][Full Text] [Related]
31. Arrest of replication fork progression at sites of topoisomerase II-mediated DNA cleavage in human leukemia CEM cells incubated with VM-26. Catapano CV; Carbone GM; Pisani F; Qiu J; Fernandes DJ Biochemistry; 1997 May; 36(19):5739-48. PubMed ID: 9153414 [TBL] [Abstract][Full Text] [Related]
32. Different topoisomerase II antitumor drugs direct similar specific long-range fragmentation of an amplified c-MYC gene locus in living cells and in high-salt-extracted nuclei. Gromova II; Thomsen B; Razin SV Proc Natl Acad Sci U S A; 1995 Jan; 92(1):102-6. PubMed ID: 7816796 [TBL] [Abstract][Full Text] [Related]
33. Nucleosome positioning as a critical determinant for the DNA cleavage sites of mammalian DNA topoisomerase II in reconstituted simian virus 40 chromatin. Capranico G; Jaxel C; Roberge M; Kohn KW; Pommier Y Nucleic Acids Res; 1990 Aug; 18(15):4553-9. PubMed ID: 2167470 [TBL] [Abstract][Full Text] [Related]
34. Topoisomerase I interaction with SV40 DNA in the presence and absence of camptothecin. Jaxel C; Kohn KW; Pommier Y Nucleic Acids Res; 1988 Dec; 16(23):11157-70. PubMed ID: 2849758 [TBL] [Abstract][Full Text] [Related]
35. Role of DNA intercalation in the inhibition of purified mouse leukemia (L1210) DNA topoisomerase II by 9-aminoacridines. Pommier Y; Covey J; Kerrigan D; Mattes W; Markovits J; Kohn KW Biochem Pharmacol; 1987 Oct; 36(20):3477-86. PubMed ID: 2823823 [TBL] [Abstract][Full Text] [Related]
36. Mechanisms of resistance to drugs that inhibit DNA topoisomerases. Beck WT; Danks MK Semin Cancer Biol; 1991 Aug; 2(4):235-44. PubMed ID: 1655118 [TBL] [Abstract][Full Text] [Related]
37. Topoisomerase II as a target of VM-26 and 4'-(9-acridinylamino)methanesulfon-m-aniside in atypical multidrug resistant human small cell lung carcinoma cells. de Jong S; Kooistra AJ; de Vries EG; Mulder NH; Zijlstra JG Cancer Res; 1993 Mar; 53(5):1064-71. PubMed ID: 8382551 [TBL] [Abstract][Full Text] [Related]
38. Topoisomerase I sites cluster asymmetrically at the ends of the simian virus 40 core origin of replication. Tsui S; Anderson ME; Tegtmeyer P J Virol; 1989 Dec; 63(12):5175-83. PubMed ID: 2555548 [TBL] [Abstract][Full Text] [Related]
39. Subcellular distribution of the alpha and beta topoisomerase II-DNA complexes stabilized by VM-26. Danks MK; Qiu J; Catapano CV; Schmidt CA; Beck WT; Fernandes DJ Biochem Pharmacol; 1994 Nov; 48(9):1785-95. PubMed ID: 7980648 [TBL] [Abstract][Full Text] [Related]
40. Association between the p170 form of human topoisomerase II and progeny viral DNA in cells infected with herpes simplex virus type 1. Ebert SN; Subramanian D; Shtrom SS; Chung IK; Parris DS; Muller MT J Virol; 1994 Feb; 68(2):1010-20. PubMed ID: 8289331 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]